Ipg Investment Advisors LLC Gilead Sciences, Inc. Transaction History

Ipg Investment Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $216,296 - $251,160	-2,990 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $187,263 - $239,857	2,990 New	2,990 $224 Million
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $210,358 - $235,891	-3,400 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $220,591 - $257,312	3,400 New	3,400 $241 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Ipg Investment Advisors LLC with notifications on news.